Assessment of the role of thrombin activatable fibrinolysis inhibitor in retinal vein occlusion


Gumus K., Kadayifcilar S., Eldem B., Ozcebe O.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, cilt.27, sa.5, ss.578-583, 2007 (SCI-Expanded) identifier identifier identifier

Özet

Purpose: To determine whether elevated levels of thrombin activatable fibrinolysis inhibitor (TAFI) may contribute to thrombotic risk for patients with retinal vein occlusion (RVO) and to investigate the possible correlations between TAR activity level and other conventional risk factors.